Table 1 Demographic and clinical characteristics of MH and Non-MH patients
Mucosal healing n (%) | Non-mucosal healing n (%) | p Value | |
|---|---|---|---|
Number of patients | 115 (33) | 233 (67) | |
Gender | 0.120 | ||
Male | 85 (35.7) | 153 (64.3) | |
Female | 30 (27.3) | 80 (72.7) | |
Smoking | 0.701 | ||
Non-smoker | 99 (32.7) | 204 (67.3) | |
Smoker | 16 (35.6) | 29 (64.4) | |
Family history of IBD | 1.000 | ||
No | 113 (33.1) | 228 (66.9) | |
Yes | 2 (28.6) | 5 (71.4) | |
Surgical history | 0.799 | ||
No | 95 (32.8) | 195 (67.2) | |
Yes | 20 (34.5) | 38 (65.5) | |
Disease location | 0.055 | ||
L1 Ileal | 41 (36.6) | 71 (63.4) | |
L2 Colonic | 13 (20.3) | 51 (79.7) | |
L3 Ileocolonic | 61 (35.5) | 111 (64.5) | |
Upper digestive tract involved | 0.412 | ||
No | 92 (32.4) | 192 (67.6) | |
Yes | 24 (37.5) | 40 (62.5) | |
Stenosis | 0.005 | ||
No | 97 (37.2) | 164 (62.8) | |
Yes | 18 (20.7) | 69 (79.3) | |
Penetrating | 0.074 | ||
No | 225 (68.0) | 106 (32.0) | |
Yes | 8 (47.1) | 9 (52.9) | |
Perianal lesion | 0.626 | ||
No | 59 (31.9) | 126 (68.1) | |
Yes | 56 (34.4) | 107 (65.6) | |
Medication treatment | |||
Corticosteroids | 0.953 | ||
No | 98 (33.1) | 198 (66.9) | |
Yes | 17 (32.7) | 35 (67.3) | |
Immunomodulators | 0.72 | ||
No | 95 (32.6) | 196 (67.4) | |
Yes | 20 (35.1) | 37 (64.9) | |
Infliximab | < 0.001 | ||
No | 39 (17.4) | 185 (82.6) | |
Yes | 76 (61.3) | 48 (38.7) | |